Stocks and Investing
Stocks and Investing
Mon, May 9, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Luke Sergott Maintained (TWST) at Buy with Decreased Target to $40 on, May 9th, 2022
Luke Sergott of Barclays, Maintained "Twist Bioscience Corporation" (TWST) at Buy with Decreased Target from $60 to $40 on, May 9th, 2022.
Luke has made no other calls on TWST in the last 4 months.
There are 2 other peers that have a rating on TWST. Out of the 2 peers that are also analyzing TWST, all agree with Luke's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Matthew Sykes of "Goldman Sachs" Maintained at Hold with Decreased Target to $55 on, Wednesday, April 13th, 2022
- Puneet Souda of "SVB Leerink" Maintained at Hold with Decreased Target to $70 on, Monday, February 7th, 2022
Contributing Sources